Aortic Repair Devices – Market Insights – United States

The US aortic repair device market will continue to experience growth, driven by robust uptake of innovative stent grafts supported by positive clinical trial results. The increasing availability of novel products will drive the increased adoption of endovascular and hybrid approaches for the treatment of more complex thoracic aortic lesions, as well as treatment of indications that are currently underpenetrated. The relatively high prices of novel endovascular products will also positively impact the market as these devices see uptake.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in the US from 2019 through 2033.

The rising penetration of endovascular and hybrid treatment of aortic diseases is a major driver of the US aortic repair device market.

What are the major factors driving rising penetration of endovascular and hybrid treatments over surgical treatment options?

Which aortic indications and anatomies are targeted by new hybrid and endovascular treatment options?

How will the anticipated launch of new devices and clinical trial outcomes affect the growth trajectory of the overall aortic repair device market?

Innovative devices supported by clinical evidence and technological integration are addressing unmet needs in the aortic repair space.

Which new device innovations are expanding the treatment capabilities of aortic stent grafts?

How will the integration of technologies from different fields impact aortic repair treatment outcomes?

How significantly will the continued expansion of the indications for endovascular aortic repair impact the aortic surgical graft and the endovascular anchor markets?

What factors could limit the adoption of the new devices?

Standardized patient monitoring and management programs are essential for the long-term safety and effectiveness of aortic repair procedures.

What are the main findings from clinical trials and retrospective observational studies on the long-term outcomes of endovascular aortic repair?

How will the findings from these studies impact patient selection and care decisions?

What efforts are companies and regulatory bodies making to establish the long-term safety and effectiveness of aortic stent grafts?